← European Medicine Shortage Tracker · all medicines

Spironolacton, butizid shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Spironolacton, butizid currently has availability issues reported in 1 European register: Austria.

Shortage  ATC C03EA14 · also listed as: SPIRONOLACTON, BUTIZID · data refreshed 5 November 2026

Key facts

As of 5 November 2026, 1 of the 10 tracked registers list current availability issues for Spironolacton, butizid, covering 1 affected product presentation. The longest-running open report was filed in Austria on 2024-01-17 and has now been open for about 34 months. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. In the WHO ATC classification, Spironolacton, butizid is coded C03EA14 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
Aldactone - Saltucin forte - Hartkapseln (PZN 0528528)
2024-01-172026-12-31Verknappung des Wirkstoffesregister ↗

Full report history (1 register entry)

Every individual register entry for Spironolacton, butizid in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATAldactone - Saltucin forte - Hartkapseln (PZN 0528528)Shortage2024-01-172026-12-31Verknappung des Wirkstoffes

Frequently asked

Is Spironolacton, butizid currently in shortage in Europe?

Yes. As of 5 November 2026, availability issues are reported in: Austria. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Spironolacton, butizid shortage expected to end?

Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Where does this Spironolacton, butizid availability data come from?

Directly from the official medicines-agency register that lists Spironolacton, butizid: BASG (Austria). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Spironolacton, butizid — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/spironolacton-butizid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Spironolacton, butizid availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/spironolacton-butizid/">Spironolacton, butizid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Spironolacton, butizid: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.